Featured Chrome Extensions:

Casey IRACs are produced by an AI that analyzes the opinion’s content to construct its analysis. While we strive for accuracy, the output may not be flawless. For a complete and precise understanding, please refer to the linked opinions above.

Keywords

appealtrialtrustwill
appealtrialtrustwill

Related Cases

In re Oshkosh Foundation, 61 Wis.2d 432, 213 N.W.2d 54, 68 A.L.R.3d 1041
View Case »
Talcott v. Talcott, 423 So.2d 951
View Case »
In re Gross’ Estate, 216 Cal.App.2d 563, 31 Cal.Rptr. 281
View Case »
In re Estate of Dye, 92 Cal.App.4th 966, 112 Cal.Rptr.2d 362, 01 Cal. Daily Op. Serv. 8744, 2001 Daily Journal D.A.R. 10,823
View Case »
Alexander v. UMB Bank, N.A., 632 S.W.3d 385
View Case »
Justia Law Link
LexisNexis Link
Westlaw Link
CourtListener Link
Oyez Link

In re Estate of Lung, 692 A.2d 1349

Facts

Van S. Lung died testate on March 28, 1991, leaving a will that included a legacy of $500,000 to eight beneficiaries, sourced from a specific stock fund. At the time of his death, the stock fund was significantly deficient, valued at only $46,266.25, which led to a legal dispute over whether the legacy was specific or demonstrative. The personal representative of the estate, Mason E. Wiggins, filed a suit to construe the will, seeking full payment of the bequests, while the trustees of the Van S. Lung Foundation argued for a specific legacy interpretation.

Van S. Lung died testate on March 28, 1991. Article Twenty–Four of his will creates a legacy bequeathing a total of $500,000 to eight enumerated individuals in amounts varying from $25,000 to $100,000.

Issue

Whether the legacy of $500,000 to eight beneficiaries in Van S. Lung's will is a specific or demonstrative legacy.

Thus the issue presented in this instance is whether certain provisions in the will of Van S. Lung are properly deemed demonstrative or specific.

Rule

Legacies may be classified as general, demonstrative, or specific, with the classification depending on the testator's intent and the availability of alternative sources in the event of a deficiency.

Legacies may be general, demonstrative, or specific.

Analysis

The court applied the presumption against specific legacies, emphasizing that the testator's intent must be clear to classify a legacy as specific. The trial judge found that Lung's language indicated an intention to create a demonstrative legacy, as he prioritized the bequests to individuals over the residuary estate. The court noted that if the legacy were deemed specific, the beneficiaries would suffer a significant loss due to the stock fund's deficiency, which further supported the conclusion that the legacy was demonstrative.

The trial judge recognized and applied the presumption that Lung did not intend to create a specific legacy.

Conclusion

The Court of Appeals affirmed the trial court's ruling that the legacy was demonstrative, concluding that there was no error in the trial judge's interpretation of the will.

The trial judge concluded that Lung intended to create a demonstrative rather than specific legacy in Article Twenty Four.

Who won?

Mason E. Wiggins, the personal representative of the estate, prevailed because the court agreed with his interpretation that the legacy was demonstrative, allowing for full payment to the beneficiaries despite the stock fund's deficiency.

The University of Virginia and John Israel, a Foundation trustee, now appeal the trial judge's finding in favor of Wiggins that the legacy is demonstrative.

You must be